Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis.
Suzanne LentzchGalina G LagosRaymond L ComenzoJeffrey A ZonderSilva PregjaKeren OsmanWei-Yann TsaiHeather LandauVaishali SanchorawalaPublished in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2020)